[Smile]_老虎社区_美港股上老虎

ehkay
2021-11-16

[Smile]

Berkshire Hathaway Started Two Key Positions In Q3, Sold These Dow Stocks<blockquote>伯克希尔哈撒韦在第三季度开始了两个关键头寸，出售了这些道指股票</blockquote>

Warren Buffett's Berkshire Hathaway(BRKB) bought Royalty Pharma(RPRX) and Floor & Decor(FND) for the

Berkshire Hathaway Started Two Key Positions In Q3, Sold These Dow Stocks<blockquote>伯克希尔哈撒韦在第三季度开始了两个关键头寸，出售了这些道指股票</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":871322198,"tweetId":"871322198","gmtCreate":1637028088064,"gmtModify":1637028088064,"author":{"id":3583290509321840,"idStr":"3583290509321840","authorId":3583290509321840,"authorIdStr":"3583290509321840","name":"ehkay","avatar":"https://static.tigerbbs.com/bf21fdc0ee5fa36576d29e4a9e31e1a8","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>[Smile]&nbsp; </body></html>","htmlText":"<html><head></head><body>[Smile]&nbsp; </body></html>","text":"[Smile]","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/871322198","repostId":1145114653,"repostType":4,"repost":{"id":"1145114653","kind":"news","pubTimestamp":1637018447,"share":"https://www.laohu8.com/m/news/1145114653?lang=zh_CN&edition=full","pubTime":"2021-11-16 07:20","market":"us","language":"en","title":"Berkshire Hathaway Started Two Key Positions In Q3, Sold These Dow Stocks<blockquote>伯克希尔哈撒韦在第三季度开始了两个关键头寸，出售了这些道指股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1145114653","media":"Investors","summary":"Warren Buffett's Berkshire Hathaway(BRKB) bought Royalty Pharma(RPRX) and Floor & Decor(FND) for the","content":"Warren Buffett's&nbsp;Berkshire Hathaway(BRKB) bought&nbsp;Royalty Pharma(RPRX) and&nbsp;Floor &amp; Decor(FND) for the first time in the third quarter, while adding to&nbsp;Chevron(CVX) and cutting stakes in drug stocks further, a 13F regulatory filing revealed. Royalty Pharma stock and Floor &amp; Decor stock jumped late.<blockquote>沃伦·巴菲特伯克希尔哈撒韦(BRKB)购买特许权制药(RPRX)和地板&amp;装饰(FND)第三季度首次，同时增加了雪佛龙(CVX)并进一步削减药品股的股份，一份13F监管文件显示。Royalty Pharma股票和Floor&amp;Decor股票尾盘上涨。</blockquote> In Q3, Buffett's Berkshire bought more than 13 million shares of Royalty Pharma, which gives investors exposure to biotech without taking big drug development risks. He also picked up more than 800,000 shares of Floor &amp; Decor, according to 13F filings tracked bywhalewisdom.com.<blockquote>第三季度，巴菲特的伯克希尔哈撒韦公司购买了超过1300万股Royalty Pharma股票，这使投资者无需承担巨大的药物开发风险即可接触生物技术。根据Whalewisdom.com追踪的13F文件，他还购买了超过800,000股Floor&amp;Decor股票。</blockquote> Meanwhile, Warren Buffett sold more shares in drug stocks, exiting&nbsp;Merck(MRK) entirely. He also slashed stakes in&nbsp;AbbVie(ABBV) and&nbsp;Bristol-Myers Squibb(BMY), after opening those positions in Q3 2020 and reducing them in Q2 2021. Buffett also pared stakes in&nbsp;Mastercard(MA) and&nbsp;Visa(V). He grew a stake in Chevron.<blockquote>与此同时，沃伦·巴菲特出售了更多制药股股票，退出默克（MRK）完全。他还削减了股份艾伯维(ABBV)和百时美施贵宝(BMY)，在2020年第三季度开设这些头寸并在2021年第二季度减少这些头寸后。巴菲特还减持了万事达卡（MA）及签证（五）。他增持了雪佛龙的股份。</blockquote> Merck, Visa and Chevron are all Dow Jones stocks.<blockquote>默克、Visa和雪佛龙都是道琼斯股票。</blockquote> Top holdings, including&nbsp;Apple(AAPL) and&nbsp;Amazon(AMZN), stayed steady.<blockquote>顶级持股，包括苹果(AAPL)和亚马逊（亚马逊），保持稳定。</blockquote> Berkshire remained a seller of stocks&nbsp;in Q3, the company said in an Nov. 6 earnings report. The regulatory 13F filing late Monday detailed changes to investing legendBuffett's Dow stocks-heavy portfolio&nbsp;last quarter.<blockquote>伯克希尔在11月6日的收益报告中表示，该公司第三季度仍然是股票卖家。周一晚间提交的13F监管文件详细介绍了上季度投资传奇巴菲特以道琼斯股票为主的投资组合的变化。</blockquote> Warren Buffett Stock Moves<blockquote>沃伦·巴菲特股票走势</blockquote> FND stock popped 7.6% in late trade on the&nbsp;stock market today, after closing down 1.4%. Royalty Pharma also gained 5.5% in Monday's aftermarket, after easing 0.5% in the regular session.<blockquote>FND股价在收盘下跌1.4%后，今天股市尾盘上涨7.6%。Royalty Pharma在常规交易中下跌0.5%后，周一盘后市场也上涨5.5%。</blockquote> News of the Berkshire chief's buys can send stocks soaring, as&nbsp;RH stock did in 2019 and 2020. Berkshire tends to keep those 13F holdings for years or even decades. Marked by low turnover and high conviction, Warren Buffett's stock portfolio is a popular model in the investment community.<blockquote>伯克希尔首席执行官买入的消息可能会导致股价飙升，就像RH股票在2019年和2020年所做的那样。伯克希尔倾向于将这些13F持股保留数年甚至数十年。沃伦·巴菲特的股票投资组合以低换手率和高信念为标志，是投资界的流行模式。</blockquote> In Q3, Berkshire's net stock sales of $1.95 billion was up from $1.1 billion in Q2 but down from Q1's $3.9 billion, marking the fourth straight quarter of selling.<blockquote>第三季度，伯克希尔的股票净销售额为19.5亿美元，高于第二季度的11亿美元，但低于第一季度的39亿美元，这是连续第四个季度出现抛售。</blockquote> Buffet's stock portfolio remains highly concentrated in a handful of companies. In Q3, 68% of its value was in&nbsp;Apple(AAPL) ($120.4 billion) and&nbsp;Bank of America(BAC) ($31.3 billion). Also,American Express(AXP) ($18.3 billion), and&nbsp;Coca-Cola(KO) ($21.9 billion).<blockquote>巴菲特的股票投资组合仍然高度集中在少数几家公司。第三季度，其价值的68%来自苹果(AAPL)（1204亿美元）和美国银行(BAC)（313亿美元）。所以，美国运通(AXP)（183亿美元），以及可口可乐（KO）（219亿美元）。</blockquote> Meanwhile, Berkshire bought back $7.6 billion in BRKB stock, up from $6 billion in Q2 and $6.6 billion in Q1. It repurchased a record $27.4 billion Berkshire Hathaway shares in 2020.<blockquote>与此同时，伯克希尔回购了76亿美元的BRKB股票，高于第二季度的60亿美元和第一季度的66亿美元。2020年，该公司回购了创纪录的274亿美元伯克希尔哈撒韦股票。</blockquote>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Berkshire Hathaway Started Two Key Positions In Q3, Sold These Dow Stocks<blockquote>伯克希尔哈撒韦在第三季度开始了两个关键头寸，出售了这些道指股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBerkshire Hathaway Started Two Key Positions In Q3, Sold These Dow Stocks<blockquote>伯克希尔哈撒韦在第三季度开始了两个关键头寸，出售了这些道指股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nInvestors2021-11-16 07:20\n\n</h4>\n</header>\n<article>\nWarren Buffett's&nbsp;Berkshire Hathaway(BRKB) bought&nbsp;Royalty Pharma(RPRX) and&nbsp;Floor &amp; Decor(FND) for the first time in the third quarter, while adding to&nbsp;Chevron(CVX) and cutting stakes in drug stocks further, a 13F regulatory filing revealed. Royalty Pharma stock and Floor &amp; Decor stock jumped late.<blockquote>沃伦·巴菲特伯克希尔哈撒韦(BRKB)购买特许权制药(RPRX)和地板&amp;装饰(FND)第三季度首次，同时增加了雪佛龙(CVX)并进一步削减药品股的股份，一份13F监管文件显示。Royalty Pharma股票和Floor&amp;Decor股票尾盘上涨。</blockquote> In Q3, Buffett's Berkshire bought more than 13 million shares of Royalty Pharma, which gives investors exposure to biotech without taking big drug development risks. He also picked up more than 800,000 shares of Floor &amp; Decor, according to 13F filings tracked bywhalewisdom.com.<blockquote>第三季度，巴菲特的伯克希尔哈撒韦公司购买了超过1300万股Royalty Pharma股票，这使投资者无需承担巨大的药物开发风险即可接触生物技术。根据Whalewisdom.com追踪的13F文件，他还购买了超过800,000股Floor&amp;Decor股票。</blockquote> Meanwhile, Warren Buffett sold more shares in drug stocks, exiting&nbsp;Merck(MRK) entirely. He also slashed stakes in&nbsp;AbbVie(ABBV) and&nbsp;Bristol-Myers Squibb(BMY), after opening those positions in Q3 2020 and reducing them in Q2 2021. Buffett also pared stakes in&nbsp;Mastercard(MA) and&nbsp;Visa(V). He grew a stake in Chevron.<blockquote>与此同时，沃伦·巴菲特出售了更多制药股股票，退出默克（MRK）完全。他还削减了股份艾伯维(ABBV)和百时美施贵宝(BMY)，在2020年第三季度开设这些头寸并在2021年第二季度减少这些头寸后。巴菲特还减持了万事达卡（MA）及签证（五）。他增持了雪佛龙的股份。</blockquote> Merck, Visa and Chevron are all Dow Jones stocks.<blockquote>默克、Visa和雪佛龙都是道琼斯股票。</blockquote> Top holdings, including&nbsp;Apple(AAPL) and&nbsp;Amazon(AMZN), stayed steady.<blockquote>顶级持股，包括苹果(AAPL)和亚马逊（亚马逊），保持稳定。</blockquote> Berkshire remained a seller of stocks&nbsp;in Q3, the company said in an Nov. 6 earnings report. The regulatory 13F filing late Monday detailed changes to investing legendBuffett's Dow stocks-heavy portfolio&nbsp;last quarter.<blockquote>伯克希尔在11月6日的收益报告中表示，该公司第三季度仍然是股票卖家。周一晚间提交的13F监管文件详细介绍了上季度投资传奇巴菲特以道琼斯股票为主的投资组合的变化。</blockquote> Warren Buffett Stock Moves<blockquote>沃伦·巴菲特股票走势</blockquote> FND stock popped 7.6% in late trade on the&nbsp;stock market today, after closing down 1.4%. Royalty Pharma also gained 5.5% in Monday's aftermarket, after easing 0.5% in the regular session.<blockquote>FND股价在收盘下跌1.4%后，今天股市尾盘上涨7.6%。Royalty Pharma在常规交易中下跌0.5%后，周一盘后市场也上涨5.5%。</blockquote> News of the Berkshire chief's buys can send stocks soaring, as&nbsp;RH stock did in 2019 and 2020. Berkshire tends to keep those 13F holdings for years or even decades. Marked by low turnover and high conviction, Warren Buffett's stock portfolio is a popular model in the investment community.<blockquote>伯克希尔首席执行官买入的消息可能会导致股价飙升，就像RH股票在2019年和2020年所做的那样。伯克希尔倾向于将这些13F持股保留数年甚至数十年。沃伦·巴菲特的股票投资组合以低换手率和高信念为标志，是投资界的流行模式。</blockquote> In Q3, Berkshire's net stock sales of $1.95 billion was up from $1.1 billion in Q2 but down from Q1's $3.9 billion, marking the fourth straight quarter of selling.<blockquote>第三季度，伯克希尔的股票净销售额为19.5亿美元，高于第二季度的11亿美元，但低于第一季度的39亿美元，这是连续第四个季度出现抛售。</blockquote> Buffet's stock portfolio remains highly concentrated in a handful of companies. In Q3, 68% of its value was in&nbsp;Apple(AAPL) ($120.4 billion) and&nbsp;Bank of America(BAC) ($31.3 billion). Also,American Express(AXP) ($18.3 billion), and&nbsp;Coca-Cola(KO) ($21.9 billion).<blockquote>巴菲特的股票投资组合仍然高度集中在少数几家公司。第三季度，其价值的68%来自苹果(AAPL)（1204亿美元）和美国银行(BAC)（313亿美元）。所以，美国运通(AXP)（183亿美元），以及可口可乐（KO）（219亿美元）。</blockquote> Meanwhile, Berkshire bought back $7.6 billion in BRKB stock, up from $6 billion in Q2 and $6.6 billion in Q1. It repurchased a record $27.4 billion Berkshire Hathaway shares in 2020.<blockquote>与此同时，伯克希尔回购了76亿美元的BRKB股票，高于第二季度的60亿美元和第一季度的66亿美元。2020年，该公司回购了创纪录的274亿美元伯克希尔哈撒韦股票。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.investors.com/news/warren-buffett-stocks-buys-sells-berkshire-hathaway-q3-2021-13f/\">Investors</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://www.investors.com/news/warren-buffett-stocks-buys-sells-berkshire-hathaway-q3-2021-13f/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145114653","content_text":"Warren Buffett's Berkshire Hathaway(BRKB) bought Royalty Pharma(RPRX) and Floor & Decor(FND) for the first time in the third quarter, while adding to Chevron(CVX) and cutting stakes in drug stocks further, a 13F regulatory filing revealed. Royalty Pharma stock and Floor & Decor stock jumped late.\nIn Q3, Buffett's Berkshire bought more than 13 million shares of Royalty Pharma, which gives investors exposure to biotech without taking big drug development risks. He also picked up more than 800,000 shares of Floor & Decor, according to 13F filings tracked bywhalewisdom.com.\nMeanwhile, Warren Buffett sold more shares in drug stocks, exiting Merck(MRK) entirely. He also slashed stakes in AbbVie(ABBV) and Bristol-Myers Squibb(BMY), after opening those positions in Q3 2020 and reducing them in Q2 2021. Buffett also pared stakes in Mastercard(MA) and Visa(V). He grew a stake in Chevron.\nMerck, Visa and Chevron are all Dow Jones stocks.\nTop holdings, including Apple(AAPL) and Amazon(AMZN), stayed steady.\nBerkshire remained a seller of stocks in Q3, the company said in an Nov. 6 earnings report. The regulatory 13F filing late Monday detailed changes to investing legendBuffett's Dow stocks-heavy portfolio last quarter.\nWarren Buffett Stock Moves\nFND stock popped 7.6% in late trade on the stock market today, after closing down 1.4%. Royalty Pharma also gained 5.5% in Monday's aftermarket, after easing 0.5% in the regular session.\nNews of the Berkshire chief's buys can send stocks soaring, as RH stock did in 2019 and 2020. Berkshire tends to keep those 13F holdings for years or even decades. Marked by low turnover and high conviction, Warren Buffett's stock portfolio is a popular model in the investment community.\nIn Q3, Berkshire's net stock sales of $1.95 billion was up from $1.1 billion in Q2 but down from Q1's $3.9 billion, marking the fourth straight quarter of selling.\nBuffet's stock portfolio remains highly concentrated in a handful of companies. In Q3, 68% of its value was in Apple(AAPL) ($120.4 billion) and Bank of America(BAC) ($31.3 billion). Also,American Express(AXP) ($18.3 billion), and Coca-Cola(KO) ($21.9 billion).\nMeanwhile, Berkshire bought back $7.6 billion in BRKB stock, up from $6 billion in Q2 and $6.6 billion in Q1. It repurchased a record $27.4 billion Berkshire Hathaway shares in 2020.","news_type":1,"symbols_score_info":{"BRK.A":0.9,"BRK.B":0.9}},"isVote":1,"tweetType":1,"viewCount":3629,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}